Abstract
New theoretic developments in transplantation biology indicate that it is possible to reduce the immunogenicity of a graft by removing antigen-presenting cells (leukocytes) from the tissue before grafting. Also becoming apparent is that cellular replacement therapy, the grafting of cells or clusters of cells, can be used to treat metabolic disorders such as type I diabetes mellitus. In the past, immune rejection has been a major problem and long-term patient immunosuppression is not warranted in patients with type I diabetes. Results of studies in animals show that under defined genetic conditions, mature islet tissue or immature fetal proislets may be transplanted across major histocompatibility barriers without a requirement for recipient immunosuppression. We are now ready to commence applying this technology clinically. These developments will initially be very experimental and limited in scope but should accelerate as data emerge from the initial trials.
Full text
PDF




Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Agostino M., Prowse S. J., Lafferty K. J. Stabilization of islet allografts by treatment of recipients with ultraviolet irradiated donor spleen cells. Aust J Exp Biol Med Sci. 1983 Oct;61(Pt 5):517–527. doi: 10.1038/icb.1983.49. [DOI] [PubMed] [Google Scholar]
- Ballinger W. F., Lacy P. E. Transplantation of intact pancreatic islets in rats. Surgery. 1972 Aug;72(2):175–186. [PubMed] [Google Scholar]
- Bowen K. M., Andrus L., Lafferty K. J. Successful allotransplantation of mouse pancreatic islets to nonimmunosuppressed recipients. Diabetes. 1980;29 (Suppl 1):98–104. doi: 10.2337/diab.29.1.s98. [DOI] [PubMed] [Google Scholar]
- Bowen K. M., Prowse S. J., Lafferty K. J. Reversal diabetes by islet transplantation: vulnerability of the established allograft. Science. 1981 Sep 11;213(4513):1261–1262. doi: 10.1126/science.6791285. [DOI] [PubMed] [Google Scholar]
- Delmonico F. L., Chase C. M., Russell P. S. Transplantation of rat islets of langerhans into diabetic mice. Transplant Proc. 1977 Mar;9(1):367–369. [PubMed] [Google Scholar]
- Donohoe J. A., Andrus L., Bowen K. M., Simeonovic C., Prowse S. J., Lafferty K. J. Cultured thyroid allografts induce a state of partial tolerance in adult recipient mice. Transplantation. 1983 Jan;35(1):62–67. doi: 10.1097/00007890-198301000-00012. [DOI] [PubMed] [Google Scholar]
- Farkas G., Karácsonyi S. Clinical transplantation of fetal human pancreatic islets. Biomed Biochim Acta. 1985;44(1):155–159. [PubMed] [Google Scholar]
- Faustman D., Hauptfeld V., Lacy P., Davie J. Demonstration of active tolerance in maintenance of established islet of Langerhans allografts. Proc Natl Acad Sci U S A. 1982 Jul;79(13):4153–4155. doi: 10.1073/pnas.79.13.4153. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Faustman D., Hauptfeld V., Lacy P., Davie J. Prolongation of murine islet allograft survival by pretreatment of islets with antibody directed to Ia determinants. Proc Natl Acad Sci U S A. 1981 Aug;78(8):5156–5159. doi: 10.1073/pnas.78.8.5156. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Frangipane L. G., Poole T. W., Barker C. F., Silvers W. K. Vulnerability of allogeneic and xenogeneic pancreatic islets to alloantisera. Transplant Proc. 1977 Mar;9(1):371–373. [PubMed] [Google Scholar]
- Lacy P. E., Davie J. M., Finke E. H. Induction of rejection of successful allografts of rat islets by donor peritoneal exudate cells. Transplantation. 1979 Nov;28(5):415–420. doi: 10.1097/00007890-197911000-00014. [DOI] [PubMed] [Google Scholar]
- Lacy P. E., Davie J. M., Finke E. H. Prolongation of islet allograft survival following in vitro culture (24 degrees C) and a single injection of ALS. Science. 1979 Apr 20;204(4390):312–313. doi: 10.1126/science.107588. [DOI] [PubMed] [Google Scholar]
- Lacy P. E., Davie J. M., Finke E. H. Prolongation of islet xenograft survival without continuous immunosuppression. Science. 1980 Jul 11;209(4453):283–285. doi: 10.1126/science.6770465. [DOI] [PubMed] [Google Scholar]
- Lacy P. E., Finke E. H., Janney C. G., Davie J. M. Prolongation of islet xenograft survival by in vitro culture of rat megaislets in 95% O2. Transplantation. 1982 Jun;33(6):588–592. doi: 10.1097/00007890-198206000-00004. [DOI] [PubMed] [Google Scholar]
- Lacy P. E., Lacy E. T., Finke E. H., Yasunami Y. An improved method for the isolation of islets from the beef pancreas. Diabetes. 1982 Aug;31 (Suppl 4):109–111. doi: 10.2337/diab.31.4.s109. [DOI] [PubMed] [Google Scholar]
- Lafferty K. J., Bootes A., Killby V. A., Burch W. Mechanism of thyroid allograft rejection. Aust J Exp Biol Med Sci. 1976 Dec;54(6):573–586. doi: 10.1038/icb.1976.58. [DOI] [PubMed] [Google Scholar]
- Lafferty K. J., Prowse S. J., Simeonovic C. J., Warren H. S. Immunobiology of tissue transplantation: a return to the passenger leukocyte concept. Annu Rev Immunol. 1983;1:143–173. doi: 10.1146/annurev.iy.01.040183.001043. [DOI] [PubMed] [Google Scholar]
- Lau H., Reemtsma K., Hardy M. A. Pancreatic islet allograft prolongation by donor-specific blood transfusions treated with ultraviolet irradiation. Science. 1983 Aug 19;221(4612):754–756. doi: 10.1126/science.6410509. [DOI] [PubMed] [Google Scholar]
- Mandel T. E., Hoffman L., Carter W. M. Long-term isografts of cultured fetal mouse pancreatic islets. The oncogenic effects of streptozotocin and the prevention of diabetic renal complications. Am J Pathol. 1981 Sep;104(3):227–236. [PMC free article] [PubMed] [Google Scholar]
- McKenzie J. L., Beard M. E., Hart D. N. Depletion of donor kidney dendritic cells prolongs graft survival. Transplant Proc. 1984 Aug;16(4):948–951. [PubMed] [Google Scholar]
- Morrow C. E., Sutherland D. E., Steffes M. W., Najarian J. S., Bach F. H. H-2 antigen class: effect on mouse islet allograft rejection. Science. 1983 Mar 18;219(4590):1337–1339. doi: 10.1126/science.6402817. [DOI] [PubMed] [Google Scholar]
- Serie J. R., Hickey G. E., Schmitt R. V., Hegre O. D. Prolongation of culture-isolated neonatal islet xenografts without immunosuppression. Transplantation. 1983 Jul;36(1):6–11. doi: 10.1097/00007890-198307000-00002. [DOI] [PubMed] [Google Scholar]
- Simeonovic C. J., Bowen K. M., Kotlarski I., Lafferty K. J. Modulation of tissue immunogenicity by organ culture. Comparison of adult islets and fetal pancreas. Transplantation. 1980 Sep;30(3):174–179. doi: 10.1097/00007890-198009000-00004. [DOI] [PubMed] [Google Scholar]
- Simeonovic C. J., Lafferty K. J. Effect of organ culture on function of transplanted foetal pancreas. Aust J Exp Biol Med Sci. 1981 Dec;59(Pt 6):707–712. [PubMed] [Google Scholar]
- Simeonovic C. J., Lafferty K. J. Immunogenicity of isolated foetal mouse proislets. Aust J Exp Biol Med Sci. 1982 Aug;60(Pt 4):391–395. doi: 10.1038/icb.1982.43. [DOI] [PubMed] [Google Scholar]
- Simeonovic C. J., Lafferty K. J. The isolation and transplantation of foetal mouse proislets. Aust J Exp Biol Med Sci. 1982 Aug;60(Pt 4):383–390. doi: 10.1038/icb.1982.42. [DOI] [PubMed] [Google Scholar]
- Weber C., Zatrigi A., Weil R., McIntosh R., Hardy M. A., Reemtsma K. Pancreatic islet isografts, allografts, and xenografts: comparison of morphology and function. Surgery. 1976 Feb;79(02):144–151. [PubMed] [Google Scholar]
- Wilson J. D., Prowse S. J., Haynes S. P. Pancreatic islet allograft function in nonimmunosuppressed conscious mice. Metabolism. 1985 Jan;34(1):92–96. doi: 10.1016/0026-0495(85)90067-8. [DOI] [PubMed] [Google Scholar]
- Yasunami Y., Lacy P. E., Finke E. H. A new site for islet transplantation--a peritoneal-omental pouch. Transplantation. 1983 Aug;36(2):181–182. doi: 10.1097/00007890-198308000-00014. [DOI] [PubMed] [Google Scholar]
